ArticleJournal of gastrointestinal oncology2024

Camrelizumab combined with apatinib for unresectable, metastatic esophageal squamous cell carcinoma: a single-center, single-arm, prospective study.

Yanli Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.